Bilobalide isolated from Ginkgo leaf tea alleviates Parkinson’s disease via suppressing neuroinflammation and remodeling gut microbiota
- 23 November 2025
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 150, 157596
Abstract
No abstract availableKeywords
Funding Information
- Youth Science Fund Project
- Ministry of Education of the People's Republic of China (KF2024004)
- Hubei Province Natural Science Foundation (2023AFD118)
- National Natural Science Foundation of China (32170394)
This publication has 43 references indexed in Scilit:
- Gut microbiota promote the propagation of pathologic α-syn from gut to brain in a gut-originated mouse model of Parkinson’s diseaseBrain, Behavior, and Immunity, 2025
- Deciphering CSU pathogenesis: Network toxicologyand molecular dynamics of DOTP exposureEcotoxicology and Environmental Safety, 2025
- The potential of dried Ginkgo Biloba leaves as a novel ingredient in fermented beverages of enhanced flavour and antioxidant propertiesFood Chemistry, 2024
- Experimental models of Parkinson's disease: Challenges and OpportunitiesEuropean Journal of Pharmacology, 2024
- Positive Effect of 6-Gingerol on Functional Plasticity of Microglia in a rat Model of LPS-induced DepressionJournal of Neuroimmune Pharmacology, 2024
- Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosisInflammopharmacology, 2022
- Hair-growth promoting effect and anti-inflammatory mechanism of Ginkgo biloba polysaccharidesCarbohydrate Polymers, 2022
- Gut-microbiota-targeted diets modulate human immune statusCell, 2021
- The Potent PDE10A Inhibitor MP-10 (PF-2545920) Suppresses Microglial Activation in LPS-Induced Neuroinflammation and MPTP-Induced Parkinson’s Disease Mouse ModelsJournal of Neuroimmune Pharmacology, 2020
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s DiseaseCell, 2016